Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin

被引:97
作者
Pangas, SA
Jorgez, CJ
Matzuk, MM
机构
[1] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[4] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.M403212200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growth differentiation factor 9 (GDF9) is an oocyte-expressed member of the transforming growth factor beta (TGF-beta) superfamily and is required for normal ovarian follicle development and female fertility. GDF9 acts as a paracrine factor and affects granulosa cell physiology. Only a few genes regulated by GDF9 are known. Our microarray analysis has identified gremlin as one of the genes up-regulated by GDF9 in cultures of granulosa cells. Gremlin is a known member of the DAN family of bone morphogenetic protein (BMP) antagonists, but its expression and function in the ovary are unknown. We have investigated the regulation of gremlin in mouse granulosa cells by GDF9 as well as other members of the TGF-beta superfamily. GDF9 and BMP4 induce gremlin, but TGF-beta does not. In addition, in cultures of granulosa cells, gremlin negatively regulates BMP4 signaling but not GDF9 activity. The expression of gremlin in the ovary was also examined by in situ hybridization. A distinct change in gremlin mRNA compartmentalization occurs during follicle development and ovulation, indicating a highly regulated expression pattern during folliculogenesis. We propose that gremlin modulates the cross-talk between GDF9 and BMP signaling that is necessary during follicle development because both ligands use components of the same signaling pathway.
引用
收藏
页码:32281 / 32286
页数:6
相关论文
共 51 条
[1]  
Albrecht UEG, 1997, MOL CELLULAR METHODS, P23
[2]   Smads as transcriptional co-modulators [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :235-243
[3]   Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists [J].
Avsian-Kretchmer, O ;
Hsueh, AJW .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (01) :1-12
[4]   Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[5]   Bone morphogenetic proteins, their antagonists, and the skeleton [J].
Canalis, E ;
Economides, AN ;
Gazzerro, E .
ENDOCRINE REVIEWS, 2003, 24 (02) :218-235
[6]   Genetic analysis of the mammalian transforming growth factor-β superfamily [J].
Chang, H ;
Brown, CW ;
Matzuk, MM .
ENDOCRINE REVIEWS, 2002, 23 (06) :787-823
[7]   GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[8]   Growth differentiation factor-9 is required during early ovarian folliculogenesis [J].
Dong, JW ;
Albertini, DF ;
Nishimori, K ;
Kumar, TR ;
Lu, NF ;
Matzuk, MM .
NATURE, 1996, 383 (6600) :531-535
[9]   Regulation of ovarian function: the role of anti-Mullerian hormone [J].
Durlinger, ALL ;
Visser, JA ;
Themmen, APN .
REPRODUCTION, 2002, 124 (05) :601-609
[10]   Paracrine actions of growth differentiation factor-9 in the mammalian ovary [J].
Elvin, JA ;
Clark, AT ;
Wang, P ;
Wolfman, NM ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :1035-1048